A network pharmacology study revealed that the main triterpenoid components of Prunella vulgaris, such as oleanolic acid, ursolic acid and betulinic acid, can target tyrosine phosphatase 1B (PTP1B), and PTP1B is a potential target for breast cancer treatment [29,30]. This evidence concerns the gene PTPN1 and breast carcinoma.